Toxicogenomics – A Drug Development Perspective - Genomic Biomarkers for Pharmaceutical Development - page 152

[248] Kayala MA, Baldi P. Cyber-T web server: differential analysis of high-throughput data. Nucleic Acids Res
2012;40(W1):W553-9.
[249] Ranagathan S, et al. Advances in translational bioinformatics and population genomics in the Asia-Paciic.
BMC Genomics 2012;(Suppl. 7):S1.
[250] Smit-McBride Z, et al. Genomes / genomics / bioinformatics. In vitro . Cell Dev Biol Anim 2012;48(7):459.
[251] Sung WK. Bioinformatics applications in genomics. Computer 2012;45(6):57-63.
[252] Carazzolle MF, et al. D-MaPs - DNA-microarray projects: web-based software for multi-platform microarray
analysis. Genet Mol Biol 2009;32(3):634-9.
[253] Chen X, et al. Supervised principal component analysis for gene set enrichment of microarray data with con-
tinuous or survival outcomes. Bioinformatics 2008;24(21):2474-81.
[254] Lajugie J, Bouhassira EE. GenPlay, a multipurpose genome analyzer and browser. Bioinformatics
2011;27(14):1889-93.
[255] Scharl T, et al. Interactive visualization of clusters in microarray data: an eficient tool for improved metabolic
analysis of E. coli. Microb Cell Fact 2009;8:37.
[256] Butte A. The use and analysis of microarray data. Nat Rev Drug Discov 2002;1(12):951-60.
[257] Cano C, et al. Intelligent system for the analysis of microarray data using principal components and estima-
tion of distribution algorithms. Expert Syst Appl 2009;36(3):4654-63.
[258] Pounds S, et al. Integrated analysis of pharmacologic, clinical and SNP microarray data using Projection
Onto the Most Interesting Statistical Evidence with Adaptive Permutation Testing. Int J Data Min Bioinform
2011;5(2):143-57.
[259] FDA guidance for industry: E15 definitions for genomics biomarkers, pharmacogenomics, pharmacogenetics,
genomic data and sample coding Categories. April 2008 ICH.